We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 114% below its sector, cheaper than its peers on earnings.
T&R Biofab Co., Ltd. is dedicated to advancing medical technology through the development of innovative devices designed for tissue regeneration and transplantation procedures. Their work primarily serves the fields of orthopedics, plastic surgery, and dentistry. The company's product line encompasses custom patient implants, such as craniomaxillofacial and dental meshes. They also provide cutting-edge bioinks for 3D bioprinting and cell culture, alongside solutions for stem cell research and delivery, and specialized coatings for laboratory scaffolds and culture dishes. This enterprise was established in 2013 and operates from its base in Siheung-si, South Korea.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 246710.KQ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
